<DOC>
	<DOCNO>NCT01451385</DOCNO>
	<brief_summary>The primary objective demonstrate safety tolerability COV795 35 day use evaluate physical exam , vital sign , pulse oximetry , clinical laboratory test , AEs .</brief_summary>
	<brief_title>Study COV795 Subjects With Osteoarthritis Chronic Low Back Pain</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<criteria>Inclusion 1 . Be consider general good health base upon medical surgical history , vital sign , pulse oximetry , physical exam , clinical lab test , electrocardiogram ( ECG ) . 2 . Be ≥18 year age . 3 . Female subject eligible pregnant , lactate plan become pregnant within next 2 month ; surgically sterile least 2 year postmenopausal , practice acceptable form birth control duration study . 4 . Male subject biologically capable child must agree use reliable method birth control duration study . 5 . Have clinical diagnosis one following : OA knee hip least one year base American College Rheumatology ( ACR ) criteria Moderate severe CLBP ( i.e . pain occur area boundary lowest rib crease buttock ) 1 ) must present least several hour day minimum 3 month , 2 ) due know malignancy , 3 ) must classify nonneuropathic , neuropathic , symptomatic 6 month LBP surgery base Quebec Task Force Classification Spinal Disorders . 6 . Have average inclinic pain score ≥3 11point ( 010 ) numerical rating scale ( NRS ) average last 24 hour screen visit . 7 . Have pain intensity score ≥4 NRS average last 24 hour baseline visit . 8 . Must , investigator 's opinion , qualify opioid therapy CLBP OA . 9 . Voluntarily provide write informed consent . Exclusion 1 . Have clinically significant condition unstable intercurrent illness would preclude study participation interfere assessment pain symptom CLBP OA would increase risk opioid related AEs . 2 . Have uncontrolled poorly control major psychiatric condition , clinically significant anxiety depression . 3 . Have active malignancy history malignancy within 2 year . 4 . Have history seizure ( except pediatric febrile seizure ) cognitive dysfunction . 5 . Have clinically significant ECG abnormality uncontrolled hypo hypertension . 6 . Had arthroscopic open surgery either knee hip select primary OA study joint within 6 month . 7 . For CLBP , surgical procedure back pain within 6 month . 8 . For CLBP subject , nerve plexus block within 1 month botulinum toxin injection lower back region within 3 month . For subject OA select primary joint , joint injection within 1 month prior Screening Visit 1 . 9 . Had surgical implant either knee hip select primary OA joint . 10 . Had gastric reduction surgery . 11 . Have take opioids equivalent 20 mg OC 40 mg MS orally per day , take opioid medication 4 time week . 12 . Unable discontinue use prohibit medication . 13 . Have know allergy hypersensitivity opioids , OC , APAP ibuprofen . 14 . Have abnormal clinical laboratory test screen . 15 . Have history substance alcohol abuse . 16 . Have positive screening labs human immunodeficiency virus ( HIV ) , Hepatitis B and/or Hepatitis C. 17 . Have positive urine drug test alcohol , illicit drug , control substance prescribe medication . 18 . Have previously participate clinical trial use COV795 . 19 . Received investigational drug device past 4 week . 20 . History spinal stenosis . 21 . Other criterion specify trial protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>